article thumbnail

Generative AI: Revolutionizing Pharmaceutical Industry and Driving Precision Medicine With Innovation, Equity and Ethics

MedCity News

The art of processing and producing valuable data, empowers researchers to identify potential drug targets, predict drug interactions, and optimize clinical trial designs, reducing time and costs associated with research endeavors and ultimately bringing the best quality medicines to meet our needs at a faster pace.

Ethics 105
article thumbnail

Psychedelics Present Unique Ethical Challenges

Pharmacy Times

Sa’ed Al-Olimat, PharmD, co-founder of the Psychedelic Pharmacists Association, discussed the future of psychedelic medicines and the unique ethical challenges they present.

Ethics 49
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Psychedelic Medicine Could Fill Care Gap in Psychiatric Care

Pharmacy Times

However, psychedelic medicine has a variety of barriers, including historical perception, access challenges, legal obstacles, and ethical questions.

article thumbnail

Improving Access to Medicine: The Role of Pharma Companies in Emerging Markets

PM360

Access to medicines have persisting and systemic differences across the globe and within countries. It is estimated that nearly two billion people globally do not have access to essential medicines. Traditionally, pharmaceutical companies have not prioritized emerging markets as part of their access strategy.

article thumbnail

Canadian and US developers to trial psychedelic medicines in UK

European Pharmaceutical Review

The UK’s regulatory pathway and fast-track drug approval process enables companies to fast-track their ethics applications and combine their reviews. The regulators are the Medicines and Healthcare products Regulatory Agency (MHRA) and US Food and Drug Administration (FDA) respectively.

article thumbnail

Staying abreast of regulations with NGS?based viral safety for faster, safer and more ethical lot release of our vaccines

European Pharmaceutical Review

Safety is key to the development of any medicine, but the safety considerations linked to bioproduction are more complex because biologics are more sophisticated medicines than small molecules. First, we see a global trend of developing more ethical solutions for the safety testing of biologics. Available from: [link].

Ethics 83
article thumbnail

Implications of AI regulation for data integrity

European Pharmaceutical Review

A study published in the Asian Journal of Advanced Research and Reports , has reported “a strong positive correlation between higher levels of regulatory compliance and perceived effectiveness in artificial intelligence (AI) implementation, as well as between AI ethics awareness and data integrity assurance.” In conclusion, Oladoyinbo et al.

Ethics 76